ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Corcept Therapeutics Inc

Corcept Therapeutics Inc (CORT)

72.51
-0.21
( -0.29% )
Updated: 12:15:59

Corcept Therapeutics Inc Financial Summary

The current CORT market cap is 7.6B. The company's latest EPS is USD 1.0130 and P/E is 71.33.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 123.6M135.41M146.81M163.8M182.55M
Operating Income 31.18M31.67M29.5M35.59M46.6M
Net Income 31.38M31.36M27.76M35.49M47.21M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 306.49M353.87M365.98M401.86M482.38M
Operating Income 111.61M128.2M124.48M98.63M107.28M
Net Income 94.18M106.01M112.51M101.42M106.14M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 594.02M621.52M655.94M714.56M784.26M
Total Liabilities 132.34M114.81M108.07M118.31M145.42M
Total Equity 461.68M506.71M547.86M596.24M638.84M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 412.31M571.73M423.76M583.43M621.52M
Total Liabilities 41.13M48.39M47.95M81.59M114.81M
Total Equity 371.18M523.34M375.81M501.84M506.71M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 121.15M127.04M23.76M64.94M138.77M
Investing 73.81M90.91M-9.01M-69.21M-113.24M
Financing -149.49M-148.72M-543k-2.69M-23.79M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 136.12M151.97M167.89M120.32M127.04M
Investing -117.83M-119.26M136.13M-114.33M90.91M
Financing -28.65M12.21M-302.59M-17.28M-148.72M
Market Cap 7.6B
Price to Earnings Ratio 71.33
Price to Sales Ratio 15.7
Price to Cash Ratio 55.86
Price to Book Ratio 14.94
Dividend Yield -

Share Statistics

Shares Outstanding 104.78M
Average Volume (1 week) 738.29k
Average Volume (1 Month) 904.16k
52 Week Change 219.29%
52 Week High 74.6114
52 Week Low 20.84
Spread (Intraday) -0.79 (-1.09%)

Company Info

Company Name Corcept Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.corcept.com
Industry pharmaceutical preparations (2834)